Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Diabetes Mellitus
/ drug therapy
Enzyme Inhibitors
/ chemical synthesis
Humans
Hypoglycemic Agents
/ chemical synthesis
Molecular Docking Simulation
Molecular Targeted Therapy
Structure-Activity Relationship
Triazoles
/ chemical synthesis
alpha-Amylases
/ antagonists & inhibitors
alpha-Glucosidases
/ metabolism
Benzotriazoles
Diabetes
In silico studies
Kinetic studies
α-Amylase inhibition
α-glucosidase inhibition
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
01 Dec 2019
01 Dec 2019
Historique:
received:
14
06
2019
revised:
09
08
2019
accepted:
02
09
2019
pubmed:
13
9
2019
medline:
15
1
2020
entrez:
13
9
2019
Statut:
ppublish
Résumé
Benzotriazoles (4-6) were synthesized which were further reacted with different substituted benzoic acids and phenacyl bromides to synthesize benzotriazole derivatives (7-40). The synthetic compounds (7-40) were characterized via different spectroscopic techniques including EI-MS, HREI-MS,
Identifiants
pubmed: 31514061
pii: S0223-5234(19)30821-9
doi: 10.1016/j.ejmech.2019.111677
pii:
doi:
Substances chimiques
Enzyme Inhibitors
0
Hypoglycemic Agents
0
Triazoles
0
benzotriazole
86110UXM5Y
alpha-Amylases
EC 3.2.1.1
alpha-Glucosidases
EC 3.2.1.20
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111677Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.